Related Experiment Videos
Australia antigen in diabetic subjects.
Acta Diabetologica Latina
|May 1, 1976
Summary
Hepatitis B virus surface antigen (HBsAg) prevalence was similar in diabetics (1.56%) and blood donors (1.64%). This study found no significant difference in HBsAg frequency between these groups, excluding those with jaundice history.
Area of Science:
- Hepatology
- Infectious Diseases
- Endocrinology
Background:
- Hepatitis B virus (HBV) infection is a global health concern.
- Hepatitis B surface antigen (HBsAg) is a key serological marker for HBV infection.
- Understanding HBsAg prevalence in different populations is crucial for public health strategies.
Purpose of the Study:
- To investigate the prevalence of HBsAg in diabetic patients compared to healthy blood donors.
- To determine if diabetes is associated with a higher risk of HBV infection.
Main Methods:
- Sera from 766 diabetic patients and 730 blood donors were tested for HBsAg.
- Individuals with a history of jaundice were excluded from both study groups.
- Standard serological assays were used for HBsAg detection.
Main Results:
- HBsAg was detected in 1.64% of blood donors.
- HBsAg was detected in 1.56% of diabetic patients.
- The frequency of HBsAg was statistically similar between the two groups.
Conclusions:
- Diabetes mellitus does not appear to be an independent risk factor for Hepatitis B virus infection.
- The prevalence of HBsAg in diabetics is comparable to that in the general blood donor population.
- Further research may explore other potential risk factors for HBV in diabetic individuals.